Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00656942 · ClinicalTrials.gov registry record
Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 419
- Enrollment target
NCT00656942: Completed study, sponsored by Massachusetts General Hospital.
NCT00656942 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 419 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00656942 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 419 participants
- Enrollment target
Study Summary
The MGH Center for Translational Pain Research is seeking patients with chronic pain for a research study. The study is looking at the effect of opioid (narcotic) pain medicines on pain sensation, threshold and tolerance.
Primary Outcome
Responses to warm/cold temperatures will be recorded by the Quantitative Sensory Testing device (QST).
Interventions
- DEVICE Quantitative Sensory Testing (QST)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 419 participants |
| Start Date | 2006-07 |
| Est. Completion | 2018-12 |
What the finished NCT00656942 record still lists
NCT00656942 is an observational study that tracks outcomes without assigning an intervention. The registered 419 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Quantitative Sensory Testing (QST) is the first listed.
NCT00656942 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00656942 about?
NCT00656942 is a clinical study titled "Pain Responses in Patients on Long-Term Opioid Therapy for Chronic Pain". The MGH Center for Translational Pain Research is seeking patients with chronic pain for a research study. The study is looking at the effect of opioid (narcotic) pain medicines on pain sensation, threshold and tolerance.
What is the current status of trial NCT00656942?
This trial is currently completed. The enrollment target is 419 participants. The study started on 2006-07. Estimated completion is 2018-12.
What interventions are being tested in trial NCT00656942?
The interventions under investigation include: Quantitative Sensory Testing (QST) (DEVICE).
Who is sponsoring clinical trial NCT00656942?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05579639 · 419 participants · Phase 2
Xylitol BSI Multisite - Reduction of Bloodstream Infections From Oral Organisms in Pediatric Stem Cell Transplant
- NCT01790152 · 420 participants
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
- NCT02701244 · 420 participants
A Registry Study of Breast Microseed Treatment
- NCT02966665 · 420 participants · Phase 1
: Vascular Function in Health and Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia